Arthur Andrew Medical was originally established in 1999 under the name Arizona Pharma Group.
It was founded by current CEO Justin Andrew Marsh. Mr. Marsh, a former engineer and contractor for companies such as Motorola, Intel and Medtronic, developed the company as a majority investor. The company specialized in the importation of enzymes and other raw materials. In 2003 Arthur Andrew Medical was formed after acquiring Thomas Arthur Aldrich, vice president and partner. Mr. Aldrich came from WNI Inc, the developers of Vitalzym. With the collaboration of well-known enzymologists and best-in-class materials, the partners began the creation of finished products under their own brand-name.
In 2003, Neprinol, the world’s most potent systemic enzyme was born. Arthur Andrew’s mission is to be the leader in the development of systemic enzyme products in the supplement industry. While other companies develop products based on market trends and fads, Arthur Andrew Medical only adopts products with ingredients that have extensive clinical research for safety and efficacy.
